The Individualized Treatment of Opioid Use Disorder

J Manag Care Spec Pharm. 2019 Jun;25(6):634-636. doi: 10.18553/jmcp.2019.25.6.634.

Abstract

No outside funding supported the writing of this commentary. Boyett is Chief Medical Officer and founder of the medical division of Pathway Healthcare, which provides treatment for opioid and other drug addictions.

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Buprenorphine / therapeutic use
  • Counseling / methods
  • Humans
  • Opioid-Related Disorders / psychology
  • Opioid-Related Disorders / therapy*
  • Social Support

Substances

  • Analgesics, Opioid
  • Buprenorphine